THIS JUST IN: Global markets are rallying as United States restrictions ease and optimism builds around reopenings in Spain, Germany, and Britain. Also helping boost the market is data out of Germany where business sentiment rose in May, beating forecasts as business expectations improved considerably, the Ifo Institute said Monday.
The market also started the holiday-shortened week buoyed by news that biotech company Novavax (NVAX) had started human trials of its vaccine candidate. That encouragement was reminiscent of last week’s boost to stocks from positive vaccine news from Moderna (MRNA).
The positive tone sent index futures sharply higher overnight, with futures on the S&P 500 Index (/ES) ticking above 3000 for the first time since early March. Treasury bonds, gold and other havens – notably the dollar – are all down, while industrial commodities, emerging market currencies are almost all higher.
*All times are in EST (GMT -5:00) NEW
3:30AM - DE: German IFO Survey 99.2 vs 99.9 est
7:00AM - MBA Mortgage Applications
10:00AM - State Street Investor Confidence Index
10:00AM - CA: Bank of Canada Announcement
10:30AM - EIA Petroleum Inventories
11:30AM - Results of $20B, 2-Year FRN Auction
Check out our wide range of educational resources including articles, videos, an immersive curriculum, webcasts, and in-person events.
Join a live webcast for real-time information on a variety of topics or watch pre-recorded sessions.
for thinkMoney ®
Financial Communications Society 2016
for Ticker Tape
Content Marketing Awards 2016
Content intended for educational/informational purposes only. Not investment advice, or a recommendation of any security, strategy, or account type.
Be sure to understand all risks involved with each strategy, including commission costs, before attempting to place any trade. Clients must consider all relevant risk factors, including their own personal financial situations, before trading.
Market volatility, volume, and system availability may delay account access and trade executions.
Past performance of a security or strategy does not guarantee future results or success.
Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses. Options trading subject to TD Ameritrade review and approval. Please read Characteristics and Risks of Standardized Options before investing in options.
Supporting documentation for any claims, comparisons, statistics, or other technical data will be supplied upon request.
This is not an offer or solicitation in any jurisdiction where we are not authorized to do business or where such offer or solicitation would be contrary to the local laws and regulations of that jurisdiction, including, but not limited to persons residing in Australia, Canada, Hong Kong, Japan, Saudi Arabia, Singapore, UK, and the countries of the European Union.
TD Ameritrade, Inc., member FINRA/SIPC. TD Ameritrade is a trademark jointly owned by TD Ameritrade IP Company, Inc. and The Toronto-Dominion Bank. © 2020 TD Ameritrade.